Profile
ACTU VRTX REGN SGEN ALNY ARGX
Company Name Actuate Therapeutics Inc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $132.24M $116.96B $55.30B $43.15B $41.50B $33.28B
Employees 0.01K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Daniel M. Schmitt Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
ACTU VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 2
Quant Rating Sell Sell Buy Neutral Strong Sell Sell
Trading
ACTU VRTX REGN SGEN ALNY ARGX
Last Close $6.74 $457.03 $547.74 $228.74 $329.77 $545.11
High 52 $11.9 $516.74 $1201.76 $228.74 $329.77 $671.75
Low 52 $5.82 $396.64 $482.92 $228.74 $224.58 $435.29
Price vs. 52 Week High -43.36 % -11.56 % -54.42 % 0 % 0 % -18.85 %
Price vs. 52 Week Low 15.81 % 15.23 % 13.42 % 0 % 46.84 % 25.23 %
Total Return
ACTU VRTX REGN SGEN ALNY ARGX
1 Month Return -30.87 % 2.36 % 12.32 % 0 % 8.53 % -5.46 %
3 Month Return -6.65 % -5.57 % -10.24 % 0 % 25.81 % -7.43 %
6 Month Return -19.81 % 12.26 % -23.73 % 0 % 40.76 % -12.18 %
9 Month Return -3.82 % 0.77 % -46.01 % 0 % 22.35 % 0.39 %
YTD Return -15.33 % 13.49 % -23.11 % 0 % 40.14 % -11.36 %
1 Year Return 0 % -2.82 % -46.51 % 0 % 32.61 % 25.23 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACTU VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ACTU VRTX REGN SGEN ALNY ARGX
Asset Growth 211.07 % -0.87 % 36.55 %
Gross Profit Growth - 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth -10.54 % -93.69 % 128.87 %
Net Income Growth -10.27 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -143.02 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -143.02 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -143.02 % 33.84 % 938.02 %
Operating Income Growth -0.75 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -1.01 % -113.93 % 80.31 %
Operating 3 Year CFG -120.41 % -118.65 % 88.36 %
Operating 5 Year CFG -120.41 % -131.3 % -135.21 %
Operating 10 Year CFG -120.41 % 12.43 % -64 %
EPS Growth -97.58 % -114.8 % 369.77 %
EPS Diluted Growth -97.58 % -114.97 % 347.67 %
Book Value Per Share 100.19 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 100.25 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 100.25 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 100.25 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth - 116.42 % 95.27 %
Free Cash Flow Growth -1.01 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACTU VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -564.49 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 88.89 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM 508.53 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 106.54 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.09 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.09 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 19.95 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -6.23 -92.97 18.31 -81.26 -550.45 -434.25
Price To Operating Cash Flows Ratio TTM -6.19 -119.36 14.06 -93.1 -914.84 -515.98
Price Cash Flow Ratio TTM -6.19 -119.36 14.06 -93.1 -914.84 -515.98
Income Statement (TTM)
ACTU VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.03B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -3.26 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACTU VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ACTU VRTX REGN SGEN ALNY ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.85
AARD Aardvark Therapeutics, Inc. Common Stock 13.52
ABCL AbCellera Biologics Inc. 3.75
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.87
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.13
ABPWW 0.0222
ABSI Absci Corporation 2.69
ABUS Arbutus Biopharma Corporation 3.19
ABVC ABVC BioPharma, Inc. 3.1
ABVX Abivax SA American Depositary Shares 7.76
ACAD ACADIA Pharmaceuticals Inc. 21.24
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.614
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.26
ACIU AC Immune SA 2.02
ETFs With Exposure to ACTU
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00077 221.03
VTI Vanguard Total Stock Market Index Fund 0 305.51
IWO iShares Russell 2000 Growth ETF 0.00184 288.53
VXF Vanguard Extended Market Index Fund 0.00034 195.67
IWC iShares Micro-Cap ETF 0.00829 131.5
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 42.28
VTSAX Vanguard Total Stock Market Index Fund 0 148.73
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00034 148.44
VITSX Vanguard Total Stock Market Index Fund 0 148.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00034 148.45
VEMPX Vanguard Extended Market Index InstlPlus 0.00034 366.31
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 279.05
RSSL Global X Funds 0 87.105
Unlock